Skip to main content

Haya Nan

Analyst

UBS (on for Ash Verma)

Equibles does not estimate personal net worth.

About Haya Nan

Haya Nan is recorded as Analyst at UBS (on for Ash Verma). Haya Nan has spoken on 1 earnings call across 1 company, most recently for Neurocrine Biosciences Inc on May 5, 2026. The companies whose calls Haya Nan spoke on are classified in the Healthcare sector.

Haya Nan on recent calls

“For INGREZA payer coverage standpoint, we saw that Osteido XR has lost preferred coverage with few key plans recently. We just wanted to understand the implications of that for INGREZA for the rest of this year and next year.”
Analyst — UBS (on for Ash Verma), Neurocrine Biosciences Inc Q1 FY2026 Earnings Call ·

Affiliation history

  • UBS (on for Ash Verma)

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity